Sign up to save your podcasts
Or
Share Episode 1: Surrogate Endpoints in AML
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Episode 1: Surrogate Endpoints in AML
Bernie Marini and Anthony Perissinotti discuss the following paper on whether or not event-free survival (EFS) is an appropriate surrogate endpoint for overall survival (OS) in AML:
Norsworthy KJ, et al. Response Rate, Event-Free Survival, and Overall Survival in Newly Diagnosed Acute Myeloid Leukemia: US Food and Drug Administration Trial-Level and Patient-Level Analyses. J Clin Oncol. 2022 Mar 10;40(8):847-854. PMID: 34890212.
View all episodes
By Bernard Marini, Anthony Perissinotti, et al.
4.5
3030 ratings
Bernie Marini and Anthony Perissinotti discuss the following paper on whether or not event-free survival (EFS) is an appropriate surrogate endpoint for overall survival (OS) in AML:
Norsworthy KJ, et al. Response Rate, Event-Free Survival, and Overall Survival in Newly Diagnosed Acute Myeloid Leukemia: US Food and Drug Administration Trial-Level and Patient-Level Analyses. J Clin Oncol. 2022 Mar 10;40(8):847-854. PMID: 34890212.
More shows like WolverHeme Happy Hour
View all
Fresh Air
38,062 Listeners
The NPR Politics Podcast
25,797 Listeners
Pod Save America
87,529 Listeners
The Daily
111,948 Listeners
Up First from NPR
56,508 Listeners
OncoPharm
188 Listeners
Today, Explained
10,282 Listeners
Interesting Times with Ross Douthat
7,230 Listeners
Blood Podcast
51 Listeners
ASTCT Talks
8 Listeners
The Ezra Klein Show
15,950 Listeners
The Weekly Show with Jon Stewart
10,745 Listeners
Blood Cancer Talks
51 Listeners
Two Onc Docs
195 Listeners
The Headlines
736 Listeners